The impact of hepatic diseases is substantial, demanding groundbreaking therapeutic modalities. Cellular therapies represent a especially hopeful avenue, offering the chance to restore damaged parenchymal tissue and enhance clinical outcomes. Currently, research focuses on several approaches, including the introduction of induced pluripotent regene